Best 3 ASX 200 healthcare shares for price growth in FY24

In terms of share price gains, this trio of healthcare companies is in rude health.

| More on:
Three health professionals at a hospital smile for the camera.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In this article, we examine the best ASX 200 healthcare shares of FY24 based on share price growth.

Here are the best performers, according to data from S & P Global Market Intelligence.

The top 3 ASX 200 healthcare shares of FY24

Pro Medicus Limited (ASX: PME)

The Pro Medicus share price was the No 1. stock of the entire S&P/ASX 200 Index (ASX: XJO) in FY24, not just the top riser among healthcare shares. Pro Medicus shares surged 118.3% in FY24.

As my colleague Bernd reports, the imaging company moved higher all year thanks to a record number of new contracts. Most recently in May, Pro Medicus announced five new contracts worth $45 million.

Pro Medicus CEO Sam Hupert said the pipeline for other contract opportunities "remains strong with a broad range of opportunities both in terms of size and market segments". Investors are also excited about the company's plans to leverage artificial intelligence to reduce costs and improve its products.

The Pro Medicus share price finished the session on Thursday at $129.41, down 5.12%.

Neuren Pharmaceuticals Ltd (ASX: NEU)

The second top-performing ASX 200 healthcare share in terms of share price growth was Neuren Pharmaceuticals, up 73.6% in FY24.

The last piece of price-sensitive news from Neuren was the top-line results from the Phase 2 clinical trial of its second drug candidate, NNZ-2591. The drug treats Pitt Hopkins syndrome (PTHS), which is a neurodevelopmental condition that causes developmental delays in children. The top-line results showed a "statistically significant improvement" across all four efficacy measures.

In 2023, the company's US marketing partner, Acadia Pharmaceuticals, reported the first full quarter of sales for Neuren's first approved drug, Daybue, which treats Rett syndrome. Net sales totalled US$66.9 million.

The Neuren Pharmaceuticals share price closed at $19.97, up 0.35% on Thursday.

Telix Pharmaceuticals Ltd (ASX: TLX)

Rounding out the top three ASX 200 healthcare shares of FY24 is Telix Pharmaceuticals, up 66.2%. Telix shares began a steady northbound trajectory in November 2023.

Telix develops highly precise diagnostic and therapeutic products to treat cancer using targeted radiation. Its diagnostic imaging can precisely locate tumours and its therapeutics can deliver isotopes directly to the cancerous cells.

Telix shares surged in April after the company released its 1Q FY24 revenue and business update. Telix was upgraded to strong buy status last month.

The Telix Pharmaceuticals share price closed at $18.18 yesterday, down 0.76%.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Pro Medicus and Telix Pharmaceuticals. The Motley Fool Australia has recommended Pro Medicus and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX investors this Tuesday.

Read more »

A man sees some good news on his phone and gives a little cheer.
Share Gainers

Why EOS, Hub24, Integrated Research, and Kingsgate shares are pushing higher

These shares are having a strong session. But why?

Read more »

happy mining worker fortescue share price
Share Gainers

Move over Lynas! How this ASX rare earths small-cap surged 106% in just 6 months

This ASX rare earths stock has more than doubled in less than half a year. But how?

Read more »

A man wearing a red jacket and mountain hiking clothes stands at the top of a mountain peak and looks out over countless mountain ranges.
Share Gainers

Here are the top 10 ASX 200 shares today

We saw another new record high for ASX shares today.

Read more »

A happy young boy in a wheelchair holds his arms outstretched as another boy pushed him.
Share Gainers

Guess which ASX All Ords stock just leapt 22% on improved guidance

Investors are sending this ASX All Ords stock rocketing on Monday. But why?

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Atturra, Bravura, Core Lithium, and Opthea shares are racing higher today

These shares are starting the week with a bang. What's happening?

Read more »

A young boy wearing a hat, sunnies and striped singlet looks fierce and flexes his arm in victory.
Share Gainers

Here are the top 10 ASX 200 shares today

It was certainly a day to remember for ASX investors this Friday...

Read more »

Three girls compete in a race, running fast around an athletic track.
Share Gainers

Do you own the 3 best performing ASX 200 shares of FY 2025?

The top three ASX 200 shares have already gained 13% to more than 20% in FY 2025!

Read more »